scholarly article | Q13442814 |
P2093 | author name string | Brown TJ | |
Marquardt H | |||
Lioubin MN | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2977-2983 | |
P577 | publication date | 1987-11-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells | |
P478 | volume | 139 |
Q36206721 | A Single Meal Containing Raw, Crushed Garlic Influences Expression of Immunity- and Cancer-Related Genes in Whole Blood of Humans |
Q33790462 | A receptor fusion protein for the inhibition of murine oncostatin M. |
Q24678972 | AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies |
Q35748007 | Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand |
Q28552291 | Anti-Tumor and Immune Enhancing Activities of Rice Bran Gramisterol on Acute Myelogenous Leukemia |
Q40134908 | Association of the oncostatin m receptor gene polymorphisms with papillary thyroid cancer in the korean population |
Q36269050 | Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ. |
Q34398986 | Characterization of the rat oncostatin M receptor complex which resembles the human, but differs from the murine cytokine receptor |
Q24600562 | Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin M |
Q54369120 | Cytostatic and cytotoxic activity of lymphokine-activated killer cell supernatants. |
Q34175664 | Early differential expression of oncostatin M in obstructive nephropathy |
Q37931055 | Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function |
Q60907233 | Endothelial signaling by neutrophil-released oncostatin M enhances P-selectin–dependent inflammation and thrombosis |
Q64118516 | Exposure to Low-Dose Radiation Enhanced the Antitumor Effect of a Dendritic Cell Vaccine |
Q35758126 | Global transcriptional analysis delineates the differential inflammatory response interleukin-15 elicits from cultured human T cells |
Q39675381 | Helicobacter pylori induces expression and secretion of oncostatin M in macrophages in vitro |
Q37253572 | Human autologous tumor-specific T cells in malignant melanoma |
Q38916641 | IFNg-induced Irgm1 promotes tumorigenesis of melanoma via dual regulation of apoptosis and Bif-1-dependent autophagy |
Q49166310 | Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer |
Q57061745 | Inflammatory cytokine oncostatin M induces endothelial activation in macro- and microvascular endothelial cells and in APOE*3Leiden.CETP mice |
Q28348472 | Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha |
Q49912481 | Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4. |
Q41045705 | Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo |
Q24633689 | Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M |
Q47332583 | Muscle cells produce a low molecular weight factor with anti-cancer activity |
Q41266798 | Myocardial healing requires Reg3β-dependent accumulation of macrophages in the ischemic heart |
Q39774148 | Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines |
Q40179542 | Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts |
Q24337530 | Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6 |
Q36076266 | Oncostatin M is a mitogen for rabbit vascular smooth muscle cells |
Q34796811 | Oncostatin M maintains the hematopoietic microenvironment in the bone marrow by modulating adipogenesis and osteogenesis |
Q28542037 | Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members |
Q24642117 | Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice |
Q36037454 | Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease |
Q33625452 | Oncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patients |
Q92700258 | Oncostatin M, an Underestimated Player in the Central Nervous System |
Q37554810 | Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes |
Q79374279 | Oncostatin m maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow |
Q38358416 | Oncostatin m modulation of lipid storage |
Q40759121 | Oncostatin m regulates mesenchymal cell differentiation and enhances hematopoietic supportive activity of bone marrow stromal cell lines |
Q41590198 | Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN. |
Q83587587 | Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma |
Q33491520 | Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer |
Q40720763 | Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia. |
Q41483216 | Specificity and function of monoclonal antibodies directed against Ewing sarcoma cells |
Q33566997 | Targeting macrophage anti-tumor activity to suppress melanoma progression |
Q39407129 | The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease |
Q35269015 | The two faces of interferon-γ in cancer |
Search more.